TTechnology Read More Pembrolizumab Hits Nearly 90% Response Rate in Desmoplastic MelanomaAugust 15, 2025 Melanoma: © David A Litman – stock.adobe.com Pembrolizumab (Keytruda) elicited a clinical response in nearly 90% of patients…
HHealth Read More Do hot drinks really give you cancer? A gut expert explainsAugust 15, 2025 When you order a coffee, do you ask for it to be “extra hot”? Whether you enjoy tea,…
SScience Read More How moving to a walkable city can add 1,100 steps to your dayAugust 15, 2025 A nationwide study shows that relocating to a more walkable city leads to sustained increases in daily steps…
HHealth Read More AI voice test could help spot dangerous throat lesions before symptoms appearAugust 15, 2025 By measuring subtle changes in voice quality, AI could help doctors detect dangerous vocal fold lesions before symptoms…
GGenetics Read More Dual epigenetic marks found to regulate cell identityAugust 14, 2025 Shedding light on what determines how cells become what they are meant to be-nerves, bone, muscles, etc.-can also…
HHealth Read More Over A Third of US Adults Are Unaware of HPVAugust 14, 2025 TOPLINE: Human papillomavirus (HPV) awareness remained critically low across the US between 2017 and 2020, with over one…
HHealth Read More Colorectal cancer rates nearly triple among younger people in SwedenAugust 14, 2025 According to a study by Karolinska Institutet, nearly three times as many people under the age of 50…
HHealth Read More PSMA PET/CT improves outcomes for men with recurrent prostate cancerAugust 14, 2025 A new study from Denmark shows for the first time that men with biochemically recurrent prostate cancer who…
HHealth Read More HonorHealth taps longevity authority Nicholas J. Schork to lead new research divisionAugust 14, 2025 Nicholas J. Schork, Ph.D., an international authority on human longevity and health maintenance, has joined HonorHealth Research Institute…
HHealth Read More New drug-releasing system eliminates tumors in 82% of high-risk bladder cancer patientsAugust 13, 2025 A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for…
HHealth Read More AI breakthrough designs peptide drugs to target previously untreatable proteinsAugust 13, 2025 A study published in Nature Biotechnology reveals a powerful new use for artificial intelligence: designing small, drug-like molecules…
HHealthcare Read More Relying on AI in colonoscopies risks eroding doctors’ skills, study warns – POLITICOAugust 13, 2025 “Our results are concerning given the adoption of AI in medicine is rapidly spreading,” said study co-author Marcin…